Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
775
-
Total shares
-
221M
-
Shares change
-
+5.84M
-
Total reported value, excl. options
-
$9.32B
-
Value change
-
+$255M
-
Put/Call ratio
-
0.64
-
Number of buys
-
370
-
Number of sells
-
-312
-
Price
-
$42.16
Significant Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q1 2017
798 filings reported holding GSK - GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM as of Q1 2017.
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) has 775 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 221M shares
.
Largest 10 shareholders include FMR LLC (23.6M shares), Fisher Asset Management, LLC (12M shares), WELLS FARGO & COMPANY/MN (11.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.7M shares), STATE STREET CORP (10.5M shares), ROYAL BANK OF CANADA (8.71M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (7.52M shares), BANK OF AMERICA CORP /DE/ (6.85M shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (6.11M shares), and Bank of New York Mellon Corp (5.91M shares).
This table shows the top 775 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.